This Article  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Kris Sperry, MD
University of New Mexico School of Medicine Albuquerque

JAMA. 1986;256(14):1893.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

In Reply.—

About an hour before the morning mail, which brought a copy of the letter by Drs Rodgers and Heymach for my review, I received a telephone call from a man in the Midwest, who had lost his wife to AFE in the early part of May, nine hours after the cesarean delivery of triplets. Now, left with six children, he is trying to understand the event that took his wife so suddenly and sought to offer the information about her clinical course to me in order that some other life might be someday saved.

I was therefore heartened to read their communication relating the successful treatment of a case of AFE with cryoprecipitate, to accomplish fibronectin repletion. As the mortality of AFE is so high (despite all known methods of support), and its occurrence so uncommon, it is clear that a sequential, controlled trial of new therapeutic modalities . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?